The use of at least one component selected from the group consisting of EGCG, hydroxytyrosol, resveratrol and derivatives, metabolites or analogues thereof in the manufacture of a nutraceutical composition for the prevention and treatment of muscle wasting leading to muscle loss, atrophy and other associated muscle disorders in animals, in particular mammals including humans.

 
Web www.patentalert.com

< Fused heterocyclic compound

> ANILINE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS

> METHOD, DEVICE AND SYSTEM FOR AUTOMATIC DETECTION OF EATING AND DRINKING

~ 00529